We identified the four novel inflammatory factors as possibly involved in macular edema: FMS-related tyrosine kinase 3 ligand (Flt-3L), fractalkine, CXC chemokine ligand 16 (CXCL-16), and endocan-1. This evidence concerns the gene CXCL16 and macular retinal edema.